‘Text/HTML’ of page ‘NRG-GI004’
Clinical Studies FAQ
Read MoreContent Block Tag: NRG-GI004
‘Text/HTML’ of page ‘NRG-GI004’
NRG-GI004/SWOG-S1610 FAQ
Read More‘Text/HTML’ of page ‘NRG-GI004’
About This Study NRG-GI004/SWOG-S1610 is a clinical trial that is studying two treatment options for patients with colorectal cancer that has spread to other parts of their body (metastatic). This study is specifically for patients who have a particular type of metastatic colorectal cancer called “MSI-high” or “DNA repair deficient” (these two terms are sometimes […]
Read More‘Text/HTML’ of page ‘NRG-GI004’
Where can I get more information? Additional information for the NRG Oncology GI004 trial can be found in the Patient Study Brochure
Read More‘Text/HTML’ of page ‘NRG-GI004’
Frequently Asked Questions About Clinical Studies What is a clinical study? Doctors and researchers conduct a clinical study, also called a “clinical trial”, to find better ways to prevent, diagnose, or treat an illness. NRG Oncology is supported by the National Cancer Institute and runs clinical studies specifically for patients with cancer or […]
Read More‘Text/HTML’ of page ‘NRG-GI004’
Frequently Asked Questions Below, you can find FAQs about clinical research and this particular clinical trial.
Read More‘Text/HTML’ of page ‘NRG-GI004’
Find a study location Are you interested in joining this study? Click the link below to find a location where this study is being conducted. Find a Participating Location
Read More‘Text/HTML’ of page ‘NRG-GI004’
About This Study NRG-GI004 is a clinical trial that will study three treatment options for patients with colorectal cancer that has spread to other parts of their body (metastatic). This study is specifically for patients who have a particular type of colorectal cancer called “MSI-high” or “DNA mismatch repair deficient”. This can usually be known by […]
Read More‘Text/HTML’ of page ‘NRG-GI004’
Read More‘Text/HTML’ of page ‘NRG-GI004’
About NRG Oncology At NRG Oncology, we focus on conducting clinical studies aimed to improve current cancer care practices and the lives of cancer patients. NRG Oncology partners with more than 1,300 member sites world-wide to research ways to improve treatment standards in the cancer community. […]
Read More